- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Lucy Scientific Discovery, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.03. | Pre-market Movers: Geron, Jet.AI, Zeo Energy, Cardlytics, Lucy Scientific Discovery | 415 | AFX News | SAN JOSE (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.00 A.M. ET).In the Green Geron Corporation (GERN) is up over 80% at $3.15.
Jet.AI... ► Artikel lesen | |
| 15.03. | COIN, MSTR and LSDI among pre-market losers | 1 | Seeking Alpha | ||
| 12.03. | Lucy Scientific Discovery, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.02. | Lucy Scientific Discovery, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.02. | Lucy Scientific Discovery, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 16.02. | Lucy Scientific announces reverse stock split to meet Nasdaq rules | 1 | Investing.com | ||
| 16.02. | Lucy Scientific Discovery announces 1-for-10 reverse stock split | 1 | Seeking Alpha | ||
| 16.02. | Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement | 281 | Business Wire | VANCOUVER, British Columbia--(BUSINESS WIRE)--Lucy Scientific Discovery Inc. (NASDAQ: LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving... ► Artikel lesen | |
| 06.02. | Lucy Scientific Discovery, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 12.01. | Lucy Scientific Discovery files to sell 7.36M shares for holders | 1 | Seeking Alpha | ||
| 12.01. | Lucy Scientific Discovery, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 18.12.23 | Lucy Scientific Discovery, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.11.23 | Lucy Scientific Discovery, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 18.10.23 | Lucy Scientific Discovery Inc.: Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health | 443 | GlobeNewswire (Europe) | DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ: LSDI) is a pioneer in alternative mental health treatments and looking to grab its share of the leadership mantle... ► Artikel lesen | |
| 13.09.23 | Lucy Scientific Discovery Inc.: Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition | 715 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / September 12, 2023 / Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a publicly traded company focused on the development, sale, delivery, and manufacturing of psychotropic... ► Artikel lesen | |
| 05.07.23 | Lucy Scientific Discovery. Inc.: Lucy Scientific Discovery, Inc. Achieves Major Milestone with Successful Completion of its Acquisition of the Assets of Wesana Health | 407 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, July 05, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "the Company") (NASDAQ: LSDI) proudly announces the successful completion of its acquisition... ► Artikel lesen | |
| 29.06.23 | Lucy Scientific Discovery. Inc.: Lucy Scientific Discovery Reiterates Its Proposal to Acquire Pasithea Therapeutics Corp. | 333 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, June 29, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "the Company") (NASDAQ: LSDI), a licensed producer of compounds for medicinal products, today... ► Artikel lesen | |
| 06.06.23 | Pasithea Therapeutics Confirms Receipt of Unsolicited Proposal from Lucy Scientific Discovery Inc. | 371 | GlobeNewswire (Europe) | PALO ALTO, Calif. and MIAMI, June 06, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) ("Pasithea" or the "Company"), a biotechnology company focused on the discovery, research... ► Artikel lesen | |
| 05.06.23 | Lucy Scientific Discovery. Inc.: Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp. | 366 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, June 05, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "the Company") (NASDAQ: LSDI), a licensed producer of compounds for medicinal products, today... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ASTRIA THERAPEUTICS | 9,000 | +7,14 % | Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported... ► Artikel lesen | |
| SOLIGENIX | 0,415 | -2,81 % | SOLIGENIX, INC. - 8-K, Current Report | ||
| ROCKET LAB USA | 3,510 | -0,28 % | How Rocket Lab Outgrew Billionaire Elon Musk's Space Company in Q1 | ||
| CHARLOTTES WEB | 0,165 | -7,30 % | Charlotte's Web Holdings Inc: Charlotte's Web to release Q1 2024 results May 8 | ||
| BOIRON | 34,150 | +1,49 % | BOIRON: Outlook 2023 - Communication calendar 2024 | The Board of Directors of Laboratoires BOIRON met on 19 December 2023, under the chairmanship of Mr Thierry Boiron.
At this meeting, the Board reviewed the latest business and earnings forecasts... ► Artikel lesen | |
| MEDICINOVA | 1,250 | 0,00 % | MediciNova, Inc.: MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting (2024 ASCO) | LA JOLLA, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange... ► Artikel lesen | |
| AMPIO | 0,181 | 0,00 % | Ampio Pharmaceuticals, Inc.: Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation | ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed in its Annual Report on Form... ► Artikel lesen | |
| AVENUE THERAPEUTICS | 0,104 | -98,20 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 25.04.2024 | Das Instrument AB2 NL0011540547 ABN AMRO BANK DR/EO1 EQUITY wird cum Kapitalmassnahme gehandelt am 25.04.2024 und ex Kapitalmassnahme am 26.04.2024 The instrument AB2 NL0011540547 ABN AMRO BANK DR/EO1... ► Artikel lesen | |
| ESSA PHARMA | 6,080 | -0,65 % | Essa Pharma Inc. Reports Results Of Annual General Meeting Of Shareholders | SOUTH SAN FRANCISCO, USA and VANCOUVER, CANADA, March 7, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical stage pharmaceutical company focused on developing... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,080 | +3,82 % | Aquestive wins FDA approval for anti-seizure therapy Libervant | ||
| HARROW | 10,530 | +5,30 % | Harrow Health, Inc. Announces Fourth Quarter and Year-End 2023 Financial Results | NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2023. The Company also... ► Artikel lesen | |
| CYANOTECH | 0,260 | 0,00 % | Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Charge Enterprises, Inc. and others from The Nasdaq Stock Market | NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of NanoString Technologies, Inc. NanoString Technologies, Inc.'s securities... ► Artikel lesen | |
| SHINECO | 0,810 | +1,39 % | Shineco, Inc.: Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement | BEIJING, March 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 1,760 | +7,65 % | Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Annual 2023 Financial Results | 2023 highlights include expanded FDA approval and new study publications
NASHVILLE, Tenn., March 5, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical... ► Artikel lesen | |
| REVIVA PHARMACEUTICALS | 2,990 | +0,34 % | Reviva Pharmaceuticals: Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia | - FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study - - Two positive 4-week studies plus a 12-month long-term safety study have potential to support a New Drug Application (NDA)... ► Artikel lesen |
Das Unternehmen LUCY SCIENTIFIC DISCOVERY INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,725 Euro und damit -16,61 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
